Prof. PeptideProf. Peptide

Everything you need for peptide research, in one place

72

Peptide profiles

75

Compounds compared

178

Verified discount codes

100%

Independent research

Certificates lab-checked in the last 7 days, as of November 9, 2026: Kylo Peptides, Artemyx Research, Endura Peptides and 6 more.

Prof. Peptide provides peptide research for educational purposes only. Nothing on this site constitutes medical advice or endorses human use of research peptides.

Everything a researcher needs

From peptide mechanisms to reconstitution math — Prof. Peptide covers it all, clearly and credibly.

Latest News

View all news

November 7, 2026

Is CagriSema Better Than Semaglutide? A Type 2 Diabetes Meta-Analysis Finds the Edge Is Weight, Not Blood Sugar

A Bayesian meta-analysis of six randomized trials in type 2 diabetes (Diabetes, Obesity & Metabolism, October 27, 2026): against semaglutide 2.4 mg, CagriSema lowered body weight a further 5.84 points (95% CrI -10.08 to -2.15), while the extra HbA1c reduction, -0.21 points, had an interval crossing zero. Against placebo, gastrointestinal events and adverse-event discontinuations were more common.

Read more →

November 6, 2026

Retatrutide for Sleep Apnea: Two Phase 3 Trials in the NEJM Report Lower Apnea-Hypopnea Index Scores

The New England Journal of Medicine published TRIUMPH-1-OSA (243 adults without type 2 diabetes) and TRIUMPH-2-OSA (448 with it) on October 21, 2026. At 80 weeks the apnea-hypopnea index changed by up to -34.3 and -25.4 events per hour with retatrutide versus about -10 with placebo. The results on both estimands, and how they sit beside tirzepatide's approved sleep apnea indication; no trial has compared the two.

Read more →

November 6, 2026

Orthopaedic Journal JAAOS Reviews BPC-157, Thymosin Beta-4 and TB-500: No Controlled Orthopaedic Evidence

A narrative review in the Journal of the American Academy of Orthopaedic Surgeons (October 27, 2026) found one small uncontrolled human case series for BPC-157 in musculoskeletal use, no controlled orthopaedic evidence for any of the three compounds, and no validated equivalence between TB-500 and full-length thymosin beta-4. It concludes that routine clinical use cannot currently be recommended.

Read more →
Why Prof. Peptide

Built for researchers

Most peptide sites exist to sell products. Prof. Peptide exists to educate. We're independent, ad-light, and committed to presenting research accurately — including limitations and unknowns.

  • ✓Content is editorially independent and research-driven
  • ✓Every peptide profile cites primary research literature
  • ✓Calculator math is transparent and peer-reviewable
  • ✓Discount codes are manually verified before publishing

Now on iOS

The all-in-one peptide tracker

Log doses, see estimated levels, calculate reconstitution, and search 70+ peptides by name or brand — all in one private iOS app.

Get the App

Don't overpay for peptides.

Prof. Peptide finds the best deals and delivers them to your inbox.